This morning, Guggenheim lowered its price target on shares of Eli Lilly (NYSE:LLY) to $61 as the company's breast cancer treatment failed in clinical trials. Despite the lower price target, Guggenheim maintained its outperform rating. Shares of Eli Lilly were lower on the news, falling 1.1% today.
Jefferies lowered its price target on shares of McCormick (NYSE:MKC) to $76 following the company's reduction in earnings guidance this week. In the report, Jefferies maintained its buy rating. Shares of McCormick were lower on Friday, slipping 1.9%.
And Stifel Nicolaus downgraded shares of Marathon Oil (NYSE:MRO) from buy to hold as the stock lacks a near-term catalyst to push it higher. Shares of MRO were lower by 1.1% on the news.
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.